Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
China Medical University has 7 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner and a distinct art unit, producing a fully distributed examination pattern. Counsel should use application-specific prosecution plans and maintain separate tracking for each examination channel.
ELSHAER, ALAAELDIN M is the busiest examiner, with 1 pending matter. The stated assignment does not identify an examiner concentration, so portfolio oversight should remain distributed across all pending matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (14%) |
| §101 + other | 2 (29%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ELSHAER, ALAAELDIN M | 1 | 35.7% | +29.8% |
| MERCIER, MELISSA S | 1 | 72.1% | +5.8% |
| EBBINGHAUS, BRIANA NOEL | 1 | 59.7% | +63.0% |
| AZPURU, CARLOS A | 1 | 83.8% | +10.8% |
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
| FONSECA LOPEZ, FRANCINI ALVARENGA | 1 | 28.6% | +30.0% |
| O'NEILL, MARISOL ANN | 1 | 54.5% | +68.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18906484 | EXPLAINABLE ARTIFICIAL INTELLIGENCE METHOD APPLIED TO CLINICAL MEDICINE AND SYSTEM THEREOF AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM | ELSHAER, ALAAELDIN M | — |
| 18802834 | Exosomes for treating glioblastoma multiforme and manufacturing method thereof | MERCIER, MELISSA S | — |
| 18761628 | CELL REPAIR-PROMOTING EXTRACELLULAR VESICLE, PRODUCTION METHOD, PREPARATION, AND USE THEREOF | EBBINGHAUS, BRIANA NOEL | — |
| 18434050 | SOLUTION FOR PRESERVING EXTRACELLULAR VESICLES/EXOSOMES, METHOD FOR PRESERVING THE SAME, AND MIXED SOLUTION THEREOF | AZPURU, CARLOS A | — |
| 18347217 | METHOD FOR REGULATING DOWNSTREAM SIGNALING PATHWAY MEDIATED BY ACTIVATION OF TRIMETHYLAMINE-N-OXIDE | RODRIGUEZ, RAYNA B | — |
| 18154906 | METHOD FOR ASSESSING DRUG-RESISTANT KLEBSIELLA PNEUMONIAE AND DRUG-RESISTANT KLEBSIELLA PNEUMONIAE ASSESSING SYSTEM | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| 17776284 | Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type | O'NEILL, MARISOL ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18906484 | EXPLAINABLE ARTIFICIAL INTELLIGENCE METHOD APPLIED TO CLINICAL MEDICINE AND SYSTEM THEREOF AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM | ELSHAER, ALAAELDIN M | — |
| 18761628 | CELL REPAIR-PROMOTING EXTRACELLULAR VESICLE, PRODUCTION METHOD, PREPARATION, AND USE THEREOF | EBBINGHAUS, BRIANA NOEL | — |
| 18434050 | SOLUTION FOR PRESERVING EXTRACELLULAR VESICLES/EXOSOMES, METHOD FOR PRESERVING THE SAME, AND MIXED SOLUTION THEREOF | AZPURU, CARLOS A | — |
| 18347217 | METHOD FOR REGULATING DOWNSTREAM SIGNALING PATHWAY MEDIATED BY ACTIVATION OF TRIMETHYLAMINE-N-OXIDE | RODRIGUEZ, RAYNA B | — |
| 18154906 | METHOD FOR ASSESSING DRUG-RESISTANT KLEBSIELLA PNEUMONIAE AND DRUG-RESISTANT KLEBSIELLA PNEUMONIAE ASSESSING SYSTEM | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| 17776284 | Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type | O'NEILL, MARISOL ANN | — |
| Art Unit | Apps |
|---|---|
| 3687 | 1 |
| 1615 | 1 |
| 1613 | 1 |
| 1617 | 1 |
| 1628 | 1 |
| 1685 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18906484 | EXPLAINABLE ARTIFICIAL INTELLIGENCE METHOD APPLIED TO CLINICAL MEDICINE AND SYSTEM THEREOF AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM | ELSHAER, ALAAELDIN M | 3687 | §101 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18802834 | Exosomes for treating glioblastoma multiforme and manufacturing method thereof | MERCIER, MELISSA S | 1615 | §103§112 | Final Rejection | — | Pending | Aug 13, 2024 |
| 18761628 | CELL REPAIR-PROMOTING EXTRACELLULAR VESICLE, PRODUCTION METHOD, PREPARATION, AND USE THEREOF | EBBINGHAUS, BRIANA NOEL | 1613 | §101§103§112 | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18434050 | SOLUTION FOR PRESERVING EXTRACELLULAR VESICLES/EXOSOMES, METHOD FOR PRESERVING THE SAME, AND MIXED SOLUTION THEREOF | AZPURU, CARLOS A | 1617 | §103§112 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18347217 | METHOD FOR REGULATING DOWNSTREAM SIGNALING PATHWAY MEDIATED BY ACTIVATION OF TRIMETHYLAMINE-N-OXIDE | RODRIGUEZ, RAYNA B | 1628 | §102§103 | Non-Final OA | — | Pending | Jul 05, 2023 |
| 18154906 | METHOD FOR ASSESSING DRUG-RESISTANT KLEBSIELLA PNEUMONIAE AND DRUG-RESISTANT KLEBSIELLA PNEUMONIAE ASSESSING SYSTEM | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103 | Final Rejection | — | Pending | Jan 16, 2023 |
| 17776284 | Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type | O'NEILL, MARISOL ANN | 1633 | §102§103§112 | Final Rejection | — | Pending | May 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChina Medical University has 7 pending office actions as of October 2026, spread across 7 art units and 7 examiners.
Alaaeldin M Elshaer has the most, with 1 of China Medical University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
